Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001948628 | SCV002208700 | uncertain significance | Axenfeld-Rieger syndrome type 3 | 2021-08-01 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with arginine at codon 270 of the FOXC1 protein (p.Gly270Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with FOXC1-related conditions. |
Fulgent Genetics, |
RCV002479484 | SCV002794422 | uncertain significance | Axenfeld-Rieger syndrome type 3; Anterior segment dysgenesis 3 | 2022-04-22 | criteria provided, single submitter | clinical testing |